Calculation of Filing Fee Tables
Form S-1
(Form Type)
Vallon Pharmaceuticals, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial effective date | Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward |
Newly Registered Securities |
Fees to Be Paid | Equity | Common Stock | Other | 3,700,000(1)(2) | $0.47(3) | $1,739,000.00 | 0.0000927 | $161.21 | | | | |
Fees Previously Paid | | | | | | | | | | | | |
Carry Forward Securities |
Carry Forward Securities | | | | | | | | | | | | |
| Total Offering Amounts | | | | $161.21 | | | | |
| Total Fees Previously Paid | | | | $0.00 | | | | |
| Total Fee Offsets | | | | $0.00 | | | | |
| Net Fee Due | | | | $161.21 | | | | |
| | | | | | | | |
| (1) | This registration statement on Form S-1 registers for resale by the selling stockholders identified in the prospectus of 3,700,000 shares of the registrant’s common stock, par value $0.0001 per share (“Common Stock”), issuable upon the exercise of warrants (the “Warrants”) held by the selling stockholders. The Warrants were issued to the selling stockholders pursuant to a private placement of securities completed on May 13, 2022. |
| (2) | Pursuant to Rule 416 under the Securities Act of 1993, as amended, there is also being registered hereby such indeterminate number of additional shares of common stock as may be issued or issuable because of stock splits, stock dividends and similar transactions. |
| (3) | Estimated in accordance with Rule 457(c) solely for purposes of calculating the registration fee. The maximum price per share and the maximum aggregate offering price are based on the average of the $0.60 (high) and $0.34 (low) sale price of the registrant’s Common Stock as reported on The Nasdaq Capital Market on May 24, 2022, which date is within five business days prior to filing of this registration statement. |